vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Northfield Bancorp, Inc. (NFBK). Click either name above to swap in a different company.
AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $41.3M, roughly 1.1× Northfield Bancorp, Inc.). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -1545.5%, a 1525.6% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 12.7%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 15.0%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.
ABCL vs NFBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $41.3M |
| Net Profit | $-8.9M | $-27.4M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | -1263.3% |
| Net Margin | -19.9% | -1545.5% |
| Revenue YoY | 788.4% | 12.7% |
| Net Profit YoY | 73.9% | -343.6% |
| EPS (diluted) | $-0.03 | $-0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $41.3M | ||
| Q3 25 | $9.0M | $39.2M | ||
| Q2 25 | $17.1M | $38.9M | ||
| Q1 25 | $4.2M | $34.8M | ||
| Q4 24 | $5.0M | $36.7M | ||
| Q3 24 | $6.5M | $31.8M | ||
| Q2 24 | $7.3M | $31.5M | ||
| Q1 24 | $10.0M | $31.3M |
| Q4 25 | $-8.9M | $-27.4M | ||
| Q3 25 | $-57.1M | $10.8M | ||
| Q2 25 | $-34.7M | $9.6M | ||
| Q1 25 | $-45.6M | $7.9M | ||
| Q4 24 | — | $11.3M | ||
| Q3 24 | $-51.1M | $6.5M | ||
| Q2 24 | $-36.9M | $6.0M | ||
| Q1 24 | $-40.6M | $6.2M |
| Q4 25 | -63.7% | -1263.3% | ||
| Q3 25 | -851.8% | 37.7% | ||
| Q2 25 | -290.2% | 35.6% | ||
| Q1 25 | -1479.6% | 31.0% | ||
| Q4 24 | — | 38.0% | ||
| Q3 24 | -1439.4% | 27.9% | ||
| Q2 24 | -1276.2% | 29.1% | ||
| Q1 24 | -551.5% | 27.2% |
| Q4 25 | -19.9% | -1545.5% | ||
| Q3 25 | -637.8% | 27.4% | ||
| Q2 25 | -203.3% | 24.6% | ||
| Q1 25 | -1077.2% | 22.6% | ||
| Q4 24 | — | 30.7% | ||
| Q3 24 | -785.4% | 20.5% | ||
| Q2 24 | -504.3% | 18.9% | ||
| Q1 24 | -408.0% | 19.9% |
| Q4 25 | $-0.03 | $-0.68 | ||
| Q3 25 | $-0.19 | $0.27 | ||
| Q2 25 | $-0.12 | $0.24 | ||
| Q1 25 | $-0.15 | $0.19 | ||
| Q4 24 | — | $0.27 | ||
| Q3 24 | $-0.17 | $0.16 | ||
| Q2 24 | $-0.13 | $0.14 | ||
| Q1 24 | $-0.14 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $164.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $690.1M |
| Total Assets | $1.4B | $5.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $164.0M | ||
| Q3 25 | $83.2M | $131.7M | ||
| Q2 25 | $92.4M | $97.6M | ||
| Q1 25 | $159.3M | $101.7M | ||
| Q4 24 | $156.3M | $167.7M | ||
| Q3 24 | $126.6M | $232.9M | ||
| Q2 24 | $148.3M | $153.5M | ||
| Q1 24 | $123.6M | $238.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $666.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $966.9M | $690.1M | ||
| Q3 25 | $964.0M | $719.6M | ||
| Q2 25 | $1.0B | $710.3M | ||
| Q1 25 | $1.0B | $711.1M | ||
| Q4 24 | $1.1B | $704.7M | ||
| Q3 24 | $1.1B | $699.6M | ||
| Q2 24 | $1.1B | $693.0M | ||
| Q1 24 | $1.1B | $698.4M |
| Q4 25 | $1.4B | $5.8B | ||
| Q3 25 | $1.4B | $5.7B | ||
| Q2 25 | $1.4B | $5.7B | ||
| Q1 25 | $1.3B | $5.7B | ||
| Q4 24 | $1.4B | $5.7B | ||
| Q3 24 | $1.4B | $5.7B | ||
| Q2 24 | $1.4B | $5.7B | ||
| Q1 24 | $1.5B | $5.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.95× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $53.7M |
| Free Cash FlowOCF − Capex | $-44.6M | $52.5M |
| FCF MarginFCF / Revenue | -99.4% | 127.1% |
| Capex IntensityCapex / Revenue | 21.9% | 2.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $89.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $53.7M | ||
| Q3 25 | $-52.6M | $13.9M | ||
| Q2 25 | $-32.4M | $14.1M | ||
| Q1 25 | $-11.6M | $9.4M | ||
| Q4 24 | $-108.6M | $31.1M | ||
| Q3 24 | $-28.9M | $14.0M | ||
| Q2 24 | $-30.0M | $6.9M | ||
| Q1 24 | $-41.7M | $4.2M |
| Q4 25 | $-44.6M | $52.5M | ||
| Q3 25 | $-61.5M | $13.6M | ||
| Q2 25 | $-45.8M | $13.9M | ||
| Q1 25 | $-22.2M | $9.2M | ||
| Q4 24 | $-187.0M | $30.0M | ||
| Q3 24 | $-47.4M | $13.7M | ||
| Q2 24 | $-50.1M | $6.7M | ||
| Q1 24 | $-65.8M | $3.8M |
| Q4 25 | -99.4% | 127.1% | ||
| Q3 25 | -687.0% | 34.6% | ||
| Q2 25 | -267.9% | 35.7% | ||
| Q1 25 | -524.0% | 26.3% | ||
| Q4 24 | -3702.8% | 81.6% | ||
| Q3 24 | -728.4% | 43.2% | ||
| Q2 24 | -683.8% | 21.1% | ||
| Q1 24 | -661.5% | 12.1% |
| Q4 25 | 21.9% | 2.8% | ||
| Q3 25 | 99.7% | 0.8% | ||
| Q2 25 | 78.2% | 0.6% | ||
| Q1 25 | 251.1% | 0.7% | ||
| Q4 24 | 1552.7% | 3.1% | ||
| Q3 24 | 284.6% | 0.7% | ||
| Q2 24 | 274.6% | 0.8% | ||
| Q1 24 | 242.5% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 2.76× | ||
| Q3 24 | — | 2.14× | ||
| Q2 24 | — | 1.16× | ||
| Q1 24 | — | 0.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
